Filing Details
- Accession Number:
- 0001181431-11-046165
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-08-18 18:38:26
- Reporting Period:
- 2011-08-09
- Filing Date:
- 2011-08-18
- Accepted Time:
- 2011-08-18 18:38:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 891288 | Questcor Pharmaceuticals Inc | QCOR | Pharmaceutical Preparations (2834) | 330476164 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1502375 | Kristine Engelke | 1300 North Kellogg Drive Suite D Anaheim CA 92807 | Corp. Controller & Pao | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-08-09 | 50 | $29.99 | 50 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The reporting person's purchase of Questcor Pharmaceuticals, Inc. Common Stock reported herein is matchable under Section 16(b) of the Securities Exchange Act of 1934 with the reporting person's sale of 50 shares of Questcor Pharmaceuticals, Inc. Common Stock at a price of $31.50 per share on August 11, 2011. The reporting person brought this matter to the attention of Questcor Pharmaceuticals, Inc. and has paid Questcor Pharmaceuticals, Inc. an amount equal to $65.39, representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs.
Billionaire Hedge Funds
